osimertinib
astrazeneca
['osimertinib', 'nsclc', 'sclc']
#esmo22 | sunday
a multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (egfrm) advanced nsclc treated with first-line (1l) osimertinib
presenter: zosia piotrowska, md, mhs ( ) 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.